{"gene":"TLK2","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":1997,"finding":"TLK2 (PKU-beta) encodes a nuclear serine/threonine protein kinase with a nuclear localization signal (NLS) in its N-terminal region; GST-fusion proteins containing the NLS localized to the nucleus, and transiently expressed PKU-beta in COS-1 cells was predominantly nuclear.","method":"cDNA cloning, GST-fusion nuclear localization assay, transient transfection in COS-1 cells","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 — direct subcellular localization experiment with functional NLS validation, single lab","pmids":["9427565"],"is_preprint":false},{"year":2016,"finding":"TLK2 amplification and overexpression mechanistically impairs Chk1/2-induced DNA damage checkpoint signaling, leading to a G2-M checkpoint defect, delayed DNA repair, and increased chromosomal instability (CIN) in breast cancer cells.","method":"TLK2 overexpression in breast cancer cell lines, checkpoint signaling assays, DNA damage repair assays, cell cycle analysis","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 2 — defined cellular phenotype with pathway placement (Chk1/2 signaling), single lab with multiple readouts","pmids":["27489360"],"is_preprint":false},{"year":2018,"finding":"TLK2 loss-of-function mutations (de novo or inherited heterozygous variants) act through a haploinsufficiency mechanism; cell line analysis from affected individuals demonstrated reduced TLK2 function in at least two subjects.","method":"Cell line functional analysis from patient-derived samples, whole-exome/genome sequencing","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 3 — functional loss demonstrated in patient cell lines, confirmed across multiple independent cases","pmids":["29861108"],"is_preprint":false},{"year":2019,"finding":"TLK2 is a substrate of the SCFFBXL3+CRY E3 ubiquitin ligase complex; both CRY1 and CRY2 recruit TLK2 to SCFFBXL3, TLK2 kinase activity is required for this interaction, and overexpression or genetic deletion of CRY1/2 decreases or enhances TLK2 protein abundance respectively, establishing circadian clock-mediated ubiquitin-dependent turnover of TLK2.","method":"Affinity purification mass spectrometry (APMS), CRY1/2 overexpression and genetic deletion, protein abundance measurements","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — APMS interactome plus genetic gain/loss-of-function showing bidirectional control of TLK2 abundance, moderate evidence","pmids":["30655559"],"is_preprint":false},{"year":2020,"finding":"Disease-associated TLK2 missense variants (p.Asp551Gly and p.Ser617Leu) strongly impair TLK2 kinase activity; BioID proximity proteomics identified interactions between TLK2 and chromatin regulators CHD7, CHD8, BRD4, and NACC1; lymphoblastoid cells with the p.Asp551Gly variant showed a more relaxed chromatin state and susceptibility to DNA damage.","method":"In vitro kinase activity assay with mutagenesis, BioID proximity proteomics, single-cell gel electrophoresis (comet assay), chromatin state analysis","journal":"Journal of medical genetics","confidence":"High","confidence_rationale":"Tier 1-2 — kinase activity mutagenesis plus BioID interactome plus chromatin/DNA damage phenotype, multiple orthogonal methods","pmids":["33323470"],"is_preprint":false},{"year":2025,"finding":"TLK2 and TLK1 are hyper-autophosphorylated at their N-termini via homo- or hetero-dimerization; this autophosphorylation masks a conserved non-canonical PIP box, suppressing recruitment to damaged chromatin; mutation of the PIP box abolishes TLK1/2 recruitment to DNA damage sites, establishing PCNA interaction as the mechanism for TLK2 localization to damaged chromatin.","method":"In vitro autophosphorylation assays, mutagenesis of PIP box, live-cell imaging of recruitment to DNA damage sites, co-immunoprecipitation with PCNA","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro assay, mutagenesis, and direct localization experiment with functional consequence, multiple orthogonal methods","pmids":["39727191"],"is_preprint":false},{"year":2025,"finding":"Calcium overload enhances TLK2 expression, multimerization, and phosphorylation, increasing its kinase activity; TLK2 overexpression triggers nuclear envelope rupture, nuclear enlargement, multinucleation, and cell cycle reentry; a protein complex involving TLK2, dynein light chain LC8, and myosin IIA mediates nuclear envelope disruption; TLK2 inhibition (RNAi or small-molecule) reduces neuronal death in calcium overload models and retinal ganglion cell degeneration in glaucoma mouse models.","method":"RNAi knockdown, small-molecule inhibition, co-immunoprecipitation of TLK2/LC8/myosin IIA complex, TLK2 overexpression with nuclear envelope phenotype readouts, mouse glaucoma model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — protein complex identification, loss-of-function with defined cellular phenotype, in vivo validation, multiple orthogonal methods","pmids":["40210858"],"is_preprint":false},{"year":2025,"finding":"TLK2 phosphorylates DYNLL1, enhancing its interaction with CTCF to promote CTCF-cohesin hub formation at the KLF4 locus, thereby regulating chromatin loop formation and cancer stemness plasticity; TLK2 suppression impairs cancer stemness and sensitizes cells to cytotoxic stress.","method":"CRISPR screen with live-cell CTCF-cohesin contact reporters, in vitro kinase assay (TLK2 phosphorylation of DYNLL1), co-immunoprecipitation of DYNLL1-CTCF interaction, chromatin conformation capture, mouse breast cancer model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — CRISPR screen, in vitro kinase assay identifying substrate, co-IP, chromatin conformation assay, and in vivo validation","pmids":["41120304"],"is_preprint":false},{"year":2023,"finding":"TLK2 knockdown suppresses amino acid synthesis by downregulating the mTORC1 pathway and ASNS expression; TLK2 directly interacts with the transcription factor ATF4 and promotes its expression, thereby regulating ASNS mRNA; mTORC1 directly interacts with ASNS protein and inhibits its ubiquitin-mediated degradation.","method":"IP-MS, TLK2 knockdown/overexpression, co-immunoprecipitation of TLK2-ATF4 and mTORC1-ASNS, ubiquitination assay, mTOR pathway inhibition/activation","journal":"Cancer gene therapy","confidence":"Medium","confidence_rationale":"Tier 2-3 — IP-MS plus co-IP plus functional pathway assays, single lab with multiple methods","pmids":["37542132"],"is_preprint":false},{"year":2026,"finding":"TLK2 undergoes nucleocytoplasmic shuttling during neuronal differentiation; neuronal differentiation promotes cytoplasmic localization of TLK2 by two mechanisms: nuclear export of full-length TLK2 and increased expression of TLK2 splice variants lacking the NLS; acute stimuli mimicking synaptic activity are sufficient to elicit nuclear export of TLK2.","method":"Splice-specific in situ hybridization, protein fractionation, live-cell imaging in rat neuroblastoma differentiation model, RNAseq analysis of splice variants","journal":"Frontiers in cellular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment with functional link to neuronal differentiation, multiple methods, single lab","pmids":["42023051"],"is_preprint":false},{"year":2024,"finding":"TLK2 inhibitors were optimized using QSAR analysis and small-molecule X-ray crystal structure of TLK2 kinase ATP-binding site, establishing the structural basis for selective inhibition of TLK2.","method":"Small-molecule X-ray crystallography, QSAR analysis, kinome profiling","journal":"European journal of medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 1 — small-molecule X-ray structure of TLK2 kinase domain, single study","pmids":["38636130"],"is_preprint":false}],"current_model":"TLK2 is a nuclear serine/threonine kinase that autophosphorylates at its N-terminus via dimerization, masking a PIP box to suppress PCNA-dependent recruitment to damaged chromatin; it phosphorylates substrates including DYNLL1 (to regulate CTCF-cohesin chromatin loops) and interacts with ATF4 and chromatin regulators CHD7/CHD8/BRD4; its protein abundance is regulated by SCFFBXL3+CRY-mediated ubiquitin-dependent degradation; in neurons, TLK2 undergoes activity-dependent nuclear export, and calcium overload activates TLK2 to drive nuclear envelope disruption and cell death via a TLK2-LC8-myosin IIA complex, while haploinsufficiency causes neurodevelopmental disorder through impaired kinase activity and chromatin maintenance."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing TLK2 as a nuclear kinase resolved the basic subcellular context for its function, showing that an N-terminal NLS directs the protein to the nucleus.","evidence":"GST-fusion NLS localization assays and transient transfection in COS-1 cells","pmids":["9427565"],"confidence":"Medium","gaps":["No substrates or biological function identified","Kinase activity not yet demonstrated in cells","Single cell type examined"]},{"year":2016,"claim":"TLK2 was placed in the DNA damage checkpoint pathway when overexpression was shown to impair Chk1/2-mediated G2-M checkpoint signaling, linking TLK2 dosage to chromosomal instability.","evidence":"TLK2 overexpression in breast cancer cell lines with checkpoint signaling and DNA repair assays","pmids":["27489360"],"confidence":"Medium","gaps":["Direct phosphorylation targets in the checkpoint pathway not identified","Mechanism of Chk1/2 impairment not resolved","Overexpression system may not reflect physiological regulation"]},{"year":2018,"claim":"Discovery that heterozygous TLK2 loss-of-function mutations cause a neurodevelopmental disorder established clinical relevance and demonstrated that half-normal TLK2 dosage is insufficient for normal brain development.","evidence":"Whole-exome/genome sequencing of affected individuals with functional validation in patient-derived cell lines","pmids":["29861108"],"confidence":"Medium","gaps":["Specific neuronal substrates and processes disrupted by haploinsufficiency unknown","Animal model recapitulation not reported","Functional assays limited to two subjects"]},{"year":2019,"claim":"Identification of TLK2 as a substrate of the SCF^FBXL3+CRY ubiquitin ligase revealed that TLK2 protein abundance is under circadian clock control, providing a post-translational regulatory layer.","evidence":"AP-MS identification of CRY1/2-TLK2 interaction; CRY overexpression decreased and CRY knockout increased TLK2 protein levels","pmids":["30655559"],"confidence":"High","gaps":["Physiological circadian oscillation of TLK2 protein not demonstrated in vivo","Ubiquitination sites on TLK2 not mapped","Downstream consequences of circadian TLK2 regulation unclear"]},{"year":2020,"claim":"Demonstration that disease-associated TLK2 missense variants abolish kinase activity and alter chromatin state linked the neurodevelopmental phenotype to impaired kinase function and chromatin maintenance, while BioID revealed an interactome including CHD7, CHD8, and BRD4.","evidence":"In vitro kinase assays with mutant TLK2, BioID proximity proteomics, comet assays in patient lymphoblastoid cells","pmids":["33323470"],"confidence":"High","gaps":["Whether CHD7/CHD8/BRD4 are direct substrates or scaffolding partners is unresolved","Causal link between relaxed chromatin and neurodevelopmental phenotype not demonstrated","BioID proximity interactions not all validated by reciprocal methods"]},{"year":2023,"claim":"Discovery that TLK2 interacts with ATF4 and promotes ASNS expression via mTORC1 extended TLK2 function to amino acid metabolism and metabolic signaling.","evidence":"IP-MS, co-immunoprecipitation of TLK2-ATF4, TLK2 knockdown/overexpression with pathway readouts","pmids":["37542132"],"confidence":"Medium","gaps":["Whether TLK2 directly phosphorylates ATF4 is not established","Mechanism linking TLK2 to mTORC1 activation is indirect","Single-lab study without independent replication"]},{"year":2025,"claim":"Resolution of TLK2's autoregulatory mechanism showed that dimerization-dependent N-terminal autophosphorylation masks a PIP box, creating a phospho-switch that gates PCNA-dependent recruitment to DNA damage sites.","evidence":"In vitro autophosphorylation assays, PIP box mutagenesis, live-cell imaging at laser-induced damage sites, co-IP with PCNA","pmids":["39727191"],"confidence":"High","gaps":["Phosphatase(s) that reverse the PIP box masking unknown","In vivo significance of PCNA-dependent recruitment for repair outcomes not tested","Relative contributions of homo- vs hetero-dimerization with TLK1 unclear"]},{"year":2025,"claim":"Identification of a TLK2–LC8–myosin IIA complex that mediates nuclear envelope rupture under calcium overload established a non-chromatin cytomechanical function for TLK2 in neuronal cell death, validated by TLK2 inhibition rescuing retinal ganglion cells in a glaucoma model.","evidence":"Co-IP of TLK2/LC8/myosin IIA, TLK2 RNAi and small-molecule inhibition, nuclear envelope phenotype assays, mouse glaucoma model","pmids":["40210858"],"confidence":"High","gaps":["Direct phosphorylation target(s) in the LC8-myosin IIA complex not mapped","Whether this pathway operates in non-neuronal cell death is unknown","Mechanism linking calcium to TLK2 multimerization and activation unresolved"]},{"year":2025,"claim":"Discovery that TLK2 phosphorylates DYNLL1 to promote CTCF-cohesin hub formation identified a direct kinase-substrate relationship controlling 3D chromatin architecture and cancer stemness.","evidence":"CRISPR screen, in vitro kinase assay of TLK2-DYNLL1, co-IP, chromatin conformation capture, mouse breast cancer model","pmids":["41120304"],"confidence":"High","gaps":["Phosphorylation site(s) on DYNLL1 not fully characterized","Whether this mechanism operates at loci beyond KLF4 is unknown","Contribution of TLK1 to the same pathway not addressed"]},{"year":2025,"claim":"Demonstration that TLK2 undergoes activity-dependent nuclear export during neuronal differentiation, combined with NLS-lacking splice variants, revealed a mechanism for compartment-specific TLK2 function in neurons.","evidence":"Splice-specific in situ hybridization, subcellular fractionation, live-cell imaging in differentiating rat neuroblastoma cells","pmids":["42023051"],"confidence":"Medium","gaps":["Cytoplasmic substrates of TLK2 in neurons not identified","Nuclear export signal and transport receptor not mapped","Findings from a neuroblastoma cell line, not confirmed in primary neurons"]},{"year":null,"claim":"Key open questions include the full spectrum of TLK2 substrates in neurons, the structural basis of TLK2 dimerization and its regulation by calcium, and whether circadian TLK2 degradation modulates chromatin maintenance or DNA repair in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No comprehensive substrate inventory exists","Full-length TLK2 dimer structure not solved","In vivo circadian oscillation of TLK2 and its functional consequences not demonstrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,4,5,6,7]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,4,5,7]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,4,5,9]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[1,5]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[4,7]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[6]},{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[3]}],"complexes":["TLK2-LC8-myosin IIA"],"partners":["PCNA","DYNLL1","CHD7","CHD8","BRD4","ATF4","CRY1","CRY2"],"other_free_text":[]},"mechanistic_narrative":"TLK2 is a nuclear serine/threonine kinase that functions in chromatin maintenance, DNA damage responses, and cell fate decisions including neuronal survival and cancer stemness. TLK2 dimerizes to autophosphorylate its N-terminus, masking a conserved PIP box that otherwise mediates PCNA-dependent recruitment to damaged chromatin, thereby providing a regulatory switch for its engagement at DNA lesions [PMID:39727191]. It phosphorylates DYNLL1 to promote CTCF-cohesin chromatin hub formation and loop organization [PMID:41120304], interacts with chromatin regulators CHD7, CHD8, and BRD4 [PMID:33323470], and its protein levels are controlled by SCF^FBXL3+CRY-mediated ubiquitin-dependent degradation linking TLK2 turnover to the circadian clock [PMID:30655559]. Heterozygous loss-of-function mutations cause a neurodevelopmental disorder through haploinsufficiency and impaired kinase activity [PMID:29861108, PMID:33323470], while calcium overload activates TLK2 to drive nuclear envelope disruption and neuronal death via a TLK2–LC8–myosin IIA complex [PMID:40210858]."},"prefetch_data":{"uniprot":{"accession":"Q86UE8","full_name":"Serine/threonine-protein kinase tousled-like 2","aliases":["HsHPK","PKU-alpha","Tousled-like kinase 2"],"length_aa":772,"mass_kda":87.7,"function":"Serine/threonine-protein kinase involved in the process of chromatin assembly and probably also DNA replication, transcription, repair, and chromosome segregation (PubMed:10523312, PubMed:11470414, PubMed:12660173, PubMed:12955071, PubMed:29955062, PubMed:33323470, PubMed:9427565). Phosphorylates the chromatin assembly factors ASF1A and ASF1B (PubMed:11470414, PubMed:20016786, PubMed:29955062, PubMed:35136069). Phosphorylation of ASF1A prevents its proteasome-mediated degradation, thereby enhancing chromatin assembly (PubMed:20016786). Negative regulator of amino acid starvation-induced autophagy (PubMed:22354037)","subcellular_location":"Nucleus; Nucleus, nucleoplasm; Cytoplasm, perinuclear region; Cytoplasm, cytoskeleton","url":"https://www.uniprot.org/uniprotkb/Q86UE8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/TLK2","classification":"Common Essential","n_dependent_lines":808,"n_total_lines":1208,"dependency_fraction":0.6688741721854304},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000146872","cell_line_id":"CID001290","localizations":[{"compartment":"nucleoplasm","grade":3},{"compartment":"nuclear_punctae","grade":1}],"interactors":[{"gene":"TLK1","stoichiometry":10.0},{"gene":"DYNLL1","stoichiometry":0.2},{"gene":"DYNLL2","stoichiometry":0.2},{"gene":"PSMD9","stoichiometry":0.2},{"gene":"H1F0","stoichiometry":0.2},{"gene":"DYNLL1;DYNLL2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001290","total_profiled":1310},"omim":[{"mim_id":"618050","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 57; MRD57","url":"https://www.omim.org/entry/618050"},{"mim_id":"609190","title":"ANTI-SILENCING FUNCTION 1B HISTONE CHAPERONE; ASF1B","url":"https://www.omim.org/entry/609190"},{"mim_id":"609189","title":"ANTI-SILENCING FUNCTION 1A HISTONE CHAPERONE; ASF1A","url":"https://www.omim.org/entry/609189"},{"mim_id":"608439","title":"TOUSLED-LIKE KINASE 2; TLK2","url":"https://www.omim.org/entry/608439"},{"mim_id":"608438","title":"TOUSLED-LIKE KINASE 1; TLK1","url":"https://www.omim.org/entry/608438"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TLK2"},"hgnc":{"alias_symbol":["PKU-ALPHA","MGC44450"],"prev_symbol":[]},"alphafold":{"accession":"Q86UE8","domains":[{"cath_id":"3.30.200.20","chopping":"452-546","consensus_level":"high","plddt":91.2152,"start":452,"end":546},{"cath_id":"1.10.510.10","chopping":"553-738","consensus_level":"high","plddt":93.9419,"start":553,"end":738},{"cath_id":"1.10.287","chopping":"272-347_400-450","consensus_level":"medium","plddt":92.3598,"start":272,"end":450}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86UE8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86UE8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86UE8-F1-predicted_aligned_error_v6.png","plddt_mean":71.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TLK2","jax_strain_url":"https://www.jax.org/strain/search?query=TLK2"},"sequence":{"accession":"Q86UE8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86UE8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86UE8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86UE8"}},"corpus_meta":[{"pmid":"29861108","id":"PMC_29861108","title":"De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.","date":"2018","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29861108","citation_count":39,"is_preprint":false},{"pmid":"27489360","id":"PMC_27489360","title":"Amplification of TLK2 Induces Genomic Instability via Impairing the G2-M Checkpoint.","date":"2016","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/27489360","citation_count":27,"is_preprint":false},{"pmid":"30655559","id":"PMC_30655559","title":"The circadian E3 ligase complex SCFFBXL3+CRY targets TLK2.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30655559","citation_count":25,"is_preprint":false},{"pmid":"12203774","id":"PMC_12203774","title":"Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patients.","date":"2002","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12203774","citation_count":20,"is_preprint":false},{"pmid":"30207834","id":"PMC_30207834","title":"TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway.","date":"2018","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30207834","citation_count":16,"is_preprint":false},{"pmid":"33323470","id":"PMC_33323470","title":"Functional analysis of TLK2 variants and their proximal interactomes implicates impaired kinase activity and chromatin maintenance defects in their pathogenesis.","date":"2020","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33323470","citation_count":16,"is_preprint":false},{"pmid":"31558842","id":"PMC_31558842","title":"Severe neurodevelopmental disease caused by a homozygous TLK2 variant.","date":"2020","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/31558842","citation_count":14,"is_preprint":false},{"pmid":"37542132","id":"PMC_37542132","title":"Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis.","date":"2023","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37542132","citation_count":12,"is_preprint":false},{"pmid":"9427565","id":"PMC_9427565","title":"cDNA cloning and chromosomal mapping of genes encoding novel protein kinases termed PKU-alpha and PKU-beta, which have nuclear localization signal.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9427565","citation_count":11,"is_preprint":false},{"pmid":"36134026","id":"PMC_36134026","title":"Comprehensive analysis of transcriptome characteristics and identification of TLK2 as a potential biomarker in dermatofibrosarcoma protuberans.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36134026","citation_count":5,"is_preprint":false},{"pmid":"40210858","id":"PMC_40210858","title":"A TLK2-mediated calcium-driven cell death pathway links neuronal degeneration to nuclear envelope disruption.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40210858","citation_count":4,"is_preprint":false},{"pmid":"41120304","id":"PMC_41120304","title":"Chromatin looping-based CRISPR screen identifies TLK2 as chromatin loop formation regulator in cancer stemness plasticity.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41120304","citation_count":2,"is_preprint":false},{"pmid":"38636130","id":"PMC_38636130","title":"Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships.","date":"2024","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38636130","citation_count":2,"is_preprint":false},{"pmid":"39538191","id":"PMC_39538191","title":"Report of one case with de novo mutation in TLK2 and literature review.","date":"2024","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/39538191","citation_count":1,"is_preprint":false},{"pmid":"38926950","id":"PMC_38926950","title":"[Effect of TLK2 Expression Regulated by MiR-21 on Proliferation and Apoptosis of Acute Myeloid Leukemia Cells].","date":"2024","source":"Zhongguo shi yan xue ye xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/38926950","citation_count":1,"is_preprint":false},{"pmid":"38712247","id":"PMC_38712247","title":"Autophosphorylation of the Tousled-like kinases TLK1 and TLK2 regulates recruitment to damaged chromatin via PCNA interaction.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38712247","citation_count":1,"is_preprint":false},{"pmid":"39296544","id":"PMC_39296544","title":"Case report: A novel TLK2 variant with a neuropsychiatric phenotype from a Chinese family.","date":"2024","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39296544","citation_count":1,"is_preprint":false},{"pmid":"39727191","id":"PMC_39727191","title":"Autophosphorylation of the Tousled-like kinases TLK1 and TLK2 regulates recruitment to damaged chromatin via PCNA interaction.","date":"2025","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/39727191","citation_count":0,"is_preprint":false},{"pmid":"38234837","id":"PMC_38234837","title":"Discovery and Optimization of Narrow Spectrum Inhibitors of Tousled Like Kinase 2 (TLK2) Using Quantitative Structure Activity Relationships.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38234837","citation_count":0,"is_preprint":false},{"pmid":"38500246","id":"PMC_38500246","title":"Exploring the role of TLK2 mutation in tropical calcific pancreatitis: an in silico and molecular dynamics simulation study.","date":"2024","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/38500246","citation_count":0,"is_preprint":false},{"pmid":"42023051","id":"PMC_42023051","title":"Neuronal differentiation and activity drive nucleocytoplasmic shuttling of the intellectual disability kinase TLK2.","date":"2026","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/42023051","citation_count":0,"is_preprint":false},{"pmid":"41931014","id":"PMC_41931014","title":"Expanding the Phenotype of TLK2-Related Neurodevelopmental Disorder: Longitudinal Presentation in Two Young Adult Females.","date":"2026","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41931014","citation_count":0,"is_preprint":false},{"pmid":"39145094","id":"PMC_39145094","title":"TLK2 promotes progression of hepatocellular carcinoma through Wnt/β-catenin signaling.","date":"2024","source":"Translational cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/39145094","citation_count":0,"is_preprint":false},{"pmid":"41878536","id":"PMC_41878536","title":"Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemia.","date":"2026","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41878536","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12571,"output_tokens":2814,"usd":0.039961},"stage2":{"model":"claude-opus-4-6","input_tokens":6139,"output_tokens":2867,"usd":0.153555},"total_usd":0.193516,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"TLK2 (PKU-beta) encodes a nuclear serine/threonine protein kinase with a nuclear localization signal (NLS) in its N-terminal region; GST-fusion proteins containing the NLS localized to the nucleus, and transiently expressed PKU-beta in COS-1 cells was predominantly nuclear.\",\n      \"method\": \"cDNA cloning, GST-fusion nuclear localization assay, transient transfection in COS-1 cells\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct subcellular localization experiment with functional NLS validation, single lab\",\n      \"pmids\": [\"9427565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TLK2 amplification and overexpression mechanistically impairs Chk1/2-induced DNA damage checkpoint signaling, leading to a G2-M checkpoint defect, delayed DNA repair, and increased chromosomal instability (CIN) in breast cancer cells.\",\n      \"method\": \"TLK2 overexpression in breast cancer cell lines, checkpoint signaling assays, DNA damage repair assays, cell cycle analysis\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined cellular phenotype with pathway placement (Chk1/2 signaling), single lab with multiple readouts\",\n      \"pmids\": [\"27489360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TLK2 loss-of-function mutations (de novo or inherited heterozygous variants) act through a haploinsufficiency mechanism; cell line analysis from affected individuals demonstrated reduced TLK2 function in at least two subjects.\",\n      \"method\": \"Cell line functional analysis from patient-derived samples, whole-exome/genome sequencing\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional loss demonstrated in patient cell lines, confirmed across multiple independent cases\",\n      \"pmids\": [\"29861108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TLK2 is a substrate of the SCFFBXL3+CRY E3 ubiquitin ligase complex; both CRY1 and CRY2 recruit TLK2 to SCFFBXL3, TLK2 kinase activity is required for this interaction, and overexpression or genetic deletion of CRY1/2 decreases or enhances TLK2 protein abundance respectively, establishing circadian clock-mediated ubiquitin-dependent turnover of TLK2.\",\n      \"method\": \"Affinity purification mass spectrometry (APMS), CRY1/2 overexpression and genetic deletion, protein abundance measurements\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — APMS interactome plus genetic gain/loss-of-function showing bidirectional control of TLK2 abundance, moderate evidence\",\n      \"pmids\": [\"30655559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Disease-associated TLK2 missense variants (p.Asp551Gly and p.Ser617Leu) strongly impair TLK2 kinase activity; BioID proximity proteomics identified interactions between TLK2 and chromatin regulators CHD7, CHD8, BRD4, and NACC1; lymphoblastoid cells with the p.Asp551Gly variant showed a more relaxed chromatin state and susceptibility to DNA damage.\",\n      \"method\": \"In vitro kinase activity assay with mutagenesis, BioID proximity proteomics, single-cell gel electrophoresis (comet assay), chromatin state analysis\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — kinase activity mutagenesis plus BioID interactome plus chromatin/DNA damage phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"33323470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TLK2 and TLK1 are hyper-autophosphorylated at their N-termini via homo- or hetero-dimerization; this autophosphorylation masks a conserved non-canonical PIP box, suppressing recruitment to damaged chromatin; mutation of the PIP box abolishes TLK1/2 recruitment to DNA damage sites, establishing PCNA interaction as the mechanism for TLK2 localization to damaged chromatin.\",\n      \"method\": \"In vitro autophosphorylation assays, mutagenesis of PIP box, live-cell imaging of recruitment to DNA damage sites, co-immunoprecipitation with PCNA\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro assay, mutagenesis, and direct localization experiment with functional consequence, multiple orthogonal methods\",\n      \"pmids\": [\"39727191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Calcium overload enhances TLK2 expression, multimerization, and phosphorylation, increasing its kinase activity; TLK2 overexpression triggers nuclear envelope rupture, nuclear enlargement, multinucleation, and cell cycle reentry; a protein complex involving TLK2, dynein light chain LC8, and myosin IIA mediates nuclear envelope disruption; TLK2 inhibition (RNAi or small-molecule) reduces neuronal death in calcium overload models and retinal ganglion cell degeneration in glaucoma mouse models.\",\n      \"method\": \"RNAi knockdown, small-molecule inhibition, co-immunoprecipitation of TLK2/LC8/myosin IIA complex, TLK2 overexpression with nuclear envelope phenotype readouts, mouse glaucoma model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — protein complex identification, loss-of-function with defined cellular phenotype, in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"40210858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TLK2 phosphorylates DYNLL1, enhancing its interaction with CTCF to promote CTCF-cohesin hub formation at the KLF4 locus, thereby regulating chromatin loop formation and cancer stemness plasticity; TLK2 suppression impairs cancer stemness and sensitizes cells to cytotoxic stress.\",\n      \"method\": \"CRISPR screen with live-cell CTCF-cohesin contact reporters, in vitro kinase assay (TLK2 phosphorylation of DYNLL1), co-immunoprecipitation of DYNLL1-CTCF interaction, chromatin conformation capture, mouse breast cancer model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — CRISPR screen, in vitro kinase assay identifying substrate, co-IP, chromatin conformation assay, and in vivo validation\",\n      \"pmids\": [\"41120304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TLK2 knockdown suppresses amino acid synthesis by downregulating the mTORC1 pathway and ASNS expression; TLK2 directly interacts with the transcription factor ATF4 and promotes its expression, thereby regulating ASNS mRNA; mTORC1 directly interacts with ASNS protein and inhibits its ubiquitin-mediated degradation.\",\n      \"method\": \"IP-MS, TLK2 knockdown/overexpression, co-immunoprecipitation of TLK2-ATF4 and mTORC1-ASNS, ubiquitination assay, mTOR pathway inhibition/activation\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — IP-MS plus co-IP plus functional pathway assays, single lab with multiple methods\",\n      \"pmids\": [\"37542132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"TLK2 undergoes nucleocytoplasmic shuttling during neuronal differentiation; neuronal differentiation promotes cytoplasmic localization of TLK2 by two mechanisms: nuclear export of full-length TLK2 and increased expression of TLK2 splice variants lacking the NLS; acute stimuli mimicking synaptic activity are sufficient to elicit nuclear export of TLK2.\",\n      \"method\": \"Splice-specific in situ hybridization, protein fractionation, live-cell imaging in rat neuroblastoma differentiation model, RNAseq analysis of splice variants\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional link to neuronal differentiation, multiple methods, single lab\",\n      \"pmids\": [\"42023051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TLK2 inhibitors were optimized using QSAR analysis and small-molecule X-ray crystal structure of TLK2 kinase ATP-binding site, establishing the structural basis for selective inhibition of TLK2.\",\n      \"method\": \"Small-molecule X-ray crystallography, QSAR analysis, kinome profiling\",\n      \"journal\": \"European journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — small-molecule X-ray structure of TLK2 kinase domain, single study\",\n      \"pmids\": [\"38636130\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TLK2 is a nuclear serine/threonine kinase that autophosphorylates at its N-terminus via dimerization, masking a PIP box to suppress PCNA-dependent recruitment to damaged chromatin; it phosphorylates substrates including DYNLL1 (to regulate CTCF-cohesin chromatin loops) and interacts with ATF4 and chromatin regulators CHD7/CHD8/BRD4; its protein abundance is regulated by SCFFBXL3+CRY-mediated ubiquitin-dependent degradation; in neurons, TLK2 undergoes activity-dependent nuclear export, and calcium overload activates TLK2 to drive nuclear envelope disruption and cell death via a TLK2-LC8-myosin IIA complex, while haploinsufficiency causes neurodevelopmental disorder through impaired kinase activity and chromatin maintenance.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TLK2 is a nuclear serine/threonine kinase that functions in chromatin maintenance, DNA damage responses, and cell fate decisions including neuronal survival and cancer stemness. TLK2 dimerizes to autophosphorylate its N-terminus, masking a conserved PIP box that otherwise mediates PCNA-dependent recruitment to damaged chromatin, thereby providing a regulatory switch for its engagement at DNA lesions [PMID:39727191]. It phosphorylates DYNLL1 to promote CTCF-cohesin chromatin hub formation and loop organization [PMID:41120304], interacts with chromatin regulators CHD7, CHD8, and BRD4 [PMID:33323470], and its protein levels are controlled by SCF^FBXL3+CRY-mediated ubiquitin-dependent degradation linking TLK2 turnover to the circadian clock [PMID:30655559]. Heterozygous loss-of-function mutations cause a neurodevelopmental disorder through haploinsufficiency and impaired kinase activity [PMID:29861108, PMID:33323470], while calcium overload activates TLK2 to drive nuclear envelope disruption and neuronal death via a TLK2–LC8–myosin IIA complex [PMID:40210858].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing TLK2 as a nuclear kinase resolved the basic subcellular context for its function, showing that an N-terminal NLS directs the protein to the nucleus.\",\n      \"evidence\": \"GST-fusion NLS localization assays and transient transfection in COS-1 cells\",\n      \"pmids\": [\"9427565\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No substrates or biological function identified\",\n        \"Kinase activity not yet demonstrated in cells\",\n        \"Single cell type examined\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"TLK2 was placed in the DNA damage checkpoint pathway when overexpression was shown to impair Chk1/2-mediated G2-M checkpoint signaling, linking TLK2 dosage to chromosomal instability.\",\n      \"evidence\": \"TLK2 overexpression in breast cancer cell lines with checkpoint signaling and DNA repair assays\",\n      \"pmids\": [\"27489360\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct phosphorylation targets in the checkpoint pathway not identified\",\n        \"Mechanism of Chk1/2 impairment not resolved\",\n        \"Overexpression system may not reflect physiological regulation\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovery that heterozygous TLK2 loss-of-function mutations cause a neurodevelopmental disorder established clinical relevance and demonstrated that half-normal TLK2 dosage is insufficient for normal brain development.\",\n      \"evidence\": \"Whole-exome/genome sequencing of affected individuals with functional validation in patient-derived cell lines\",\n      \"pmids\": [\"29861108\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific neuronal substrates and processes disrupted by haploinsufficiency unknown\",\n        \"Animal model recapitulation not reported\",\n        \"Functional assays limited to two subjects\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of TLK2 as a substrate of the SCF^FBXL3+CRY ubiquitin ligase revealed that TLK2 protein abundance is under circadian clock control, providing a post-translational regulatory layer.\",\n      \"evidence\": \"AP-MS identification of CRY1/2-TLK2 interaction; CRY overexpression decreased and CRY knockout increased TLK2 protein levels\",\n      \"pmids\": [\"30655559\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physiological circadian oscillation of TLK2 protein not demonstrated in vivo\",\n        \"Ubiquitination sites on TLK2 not mapped\",\n        \"Downstream consequences of circadian TLK2 regulation unclear\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstration that disease-associated TLK2 missense variants abolish kinase activity and alter chromatin state linked the neurodevelopmental phenotype to impaired kinase function and chromatin maintenance, while BioID revealed an interactome including CHD7, CHD8, and BRD4.\",\n      \"evidence\": \"In vitro kinase assays with mutant TLK2, BioID proximity proteomics, comet assays in patient lymphoblastoid cells\",\n      \"pmids\": [\"33323470\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether CHD7/CHD8/BRD4 are direct substrates or scaffolding partners is unresolved\",\n        \"Causal link between relaxed chromatin and neurodevelopmental phenotype not demonstrated\",\n        \"BioID proximity interactions not all validated by reciprocal methods\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery that TLK2 interacts with ATF4 and promotes ASNS expression via mTORC1 extended TLK2 function to amino acid metabolism and metabolic signaling.\",\n      \"evidence\": \"IP-MS, co-immunoprecipitation of TLK2-ATF4, TLK2 knockdown/overexpression with pathway readouts\",\n      \"pmids\": [\"37542132\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether TLK2 directly phosphorylates ATF4 is not established\",\n        \"Mechanism linking TLK2 to mTORC1 activation is indirect\",\n        \"Single-lab study without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Resolution of TLK2's autoregulatory mechanism showed that dimerization-dependent N-terminal autophosphorylation masks a PIP box, creating a phospho-switch that gates PCNA-dependent recruitment to DNA damage sites.\",\n      \"evidence\": \"In vitro autophosphorylation assays, PIP box mutagenesis, live-cell imaging at laser-induced damage sites, co-IP with PCNA\",\n      \"pmids\": [\"39727191\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Phosphatase(s) that reverse the PIP box masking unknown\",\n        \"In vivo significance of PCNA-dependent recruitment for repair outcomes not tested\",\n        \"Relative contributions of homo- vs hetero-dimerization with TLK1 unclear\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identification of a TLK2–LC8–myosin IIA complex that mediates nuclear envelope rupture under calcium overload established a non-chromatin cytomechanical function for TLK2 in neuronal cell death, validated by TLK2 inhibition rescuing retinal ganglion cells in a glaucoma model.\",\n      \"evidence\": \"Co-IP of TLK2/LC8/myosin IIA, TLK2 RNAi and small-molecule inhibition, nuclear envelope phenotype assays, mouse glaucoma model\",\n      \"pmids\": [\"40210858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct phosphorylation target(s) in the LC8-myosin IIA complex not mapped\",\n        \"Whether this pathway operates in non-neuronal cell death is unknown\",\n        \"Mechanism linking calcium to TLK2 multimerization and activation unresolved\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that TLK2 phosphorylates DYNLL1 to promote CTCF-cohesin hub formation identified a direct kinase-substrate relationship controlling 3D chromatin architecture and cancer stemness.\",\n      \"evidence\": \"CRISPR screen, in vitro kinase assay of TLK2-DYNLL1, co-IP, chromatin conformation capture, mouse breast cancer model\",\n      \"pmids\": [\"41120304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Phosphorylation site(s) on DYNLL1 not fully characterized\",\n        \"Whether this mechanism operates at loci beyond KLF4 is unknown\",\n        \"Contribution of TLK1 to the same pathway not addressed\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstration that TLK2 undergoes activity-dependent nuclear export during neuronal differentiation, combined with NLS-lacking splice variants, revealed a mechanism for compartment-specific TLK2 function in neurons.\",\n      \"evidence\": \"Splice-specific in situ hybridization, subcellular fractionation, live-cell imaging in differentiating rat neuroblastoma cells\",\n      \"pmids\": [\"42023051\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Cytoplasmic substrates of TLK2 in neurons not identified\",\n        \"Nuclear export signal and transport receptor not mapped\",\n        \"Findings from a neuroblastoma cell line, not confirmed in primary neurons\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the full spectrum of TLK2 substrates in neurons, the structural basis of TLK2 dimerization and its regulation by calcium, and whether circadian TLK2 degradation modulates chromatin maintenance or DNA repair in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No comprehensive substrate inventory exists\",\n        \"Full-length TLK2 dimer structure not solved\",\n        \"In vivo circadian oscillation of TLK2 and its functional consequences not demonstrated\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 4, 5, 6, 7]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 4, 5, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 4, 5, 9]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [4, 7]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [\n      \"TLK2-LC8-myosin IIA\"\n    ],\n    \"partners\": [\n      \"PCNA\",\n      \"DYNLL1\",\n      \"CHD7\",\n      \"CHD8\",\n      \"BRD4\",\n      \"ATF4\",\n      \"CRY1\",\n      \"CRY2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}